All HHS Contracts — September 24, 2026

The fully funded, firm-fixed-price delivery order provides Mortenson with a stable ~$55.3 million annual revenue stream over 4.3 years, won via full and open competition, signaling strong competitive positioning.

Firm-fixed-price structure on a $237.8 million construction project exposes M. A. Mortenson Company to cost overrun risk if design-build execution faces delays or material cost escalation.

This single contract represents a material portion of Mortenson's revenue, creating concentration risk if future NIH awards do not materialize.

The NIH's investment in specialized research facilities signals sustained federal funding for biomedical infrastructure, creating potential follow-on awards for M. A. Mortenson Company and other construction firms.

The $237.8 million award for a clinical and computational science building underscores NIH's commitment to upgrading research facilities, a stable civilian spending theme.

{"entity" => "M. A. Mortenson Company", "reason" => "Execution risk on a large firm-fixed-price contract; revenue recognition starting in 2027.", "trigger" => "Quarterly earnings reports for cost overruns or change orders; NIH budget announcements"}

{"entity" => "NIH Construction Budget", "reason" => "Follow-on awards and overall facility modernization pipeline depend on NIH budget stability.", "trigger" => "FY2027 budget proposal and appropriations cycle"}